Navigation Links
NEUMANN Diagnostics' Automated Cervical Cancer Test Achieves Exceptional Accuracy
Date:2/3/2016

BUDAPEST, Hungary, Feb. 3, 2016 /PRNewswire/ -- Molecular assays developer NEUMANN Diagnostics Ltd. today unveiled its CONFIDENCE™ molecular test portfolio setting a new standard in cervical cancer screening.

The tests demonstrated superior accuracy achieving very high sensitivity without compromising on specificity. In HPV-positive women aged 25 years or older sensitivity for severe cervical dysplasia or worse condition at baseline was 91.94% (95% CI 82.17 – 97.33) meanwhile specificity in the same group was 74.35% (95% CI 71.78 – 76.81).

The CONFIDENCE™ test portfolio (consisting of a human papillomavirus test (HPV) and an epigenetic biomarker) was evaluated in a multicentre clinical trial involving over 7,000 cervical samples collected from over 6,000 women. This clinical trial makes the CONFIDENCE™ biomarker the most validated epigenetic biomarker for cervical cancer diagnostics.

"We are very pleased with the results of the study. This is the first highly accurate screening method in the world with fully automated evaluation," said Miklós Nyíri, managing director of NEUMANN.

Initially NEUMANN intends to introduce the test to complement current screening methods. Its biomarker test can help substantially increase the sensitivity of Pap testing without impacting specificity. 

"What is needed the most today is increasing sensitivity of the current screening system and finding women in need of treatment as early as possible" – said Nyíri. "We recommend using the CONFIDENCE™ tests on all samples which did not get a severe dysplasia diagnosis – because there is a potentially undetected underlying disease."

In the clinical trial the CONFIDENCE™ tests found severe cases up to 12 months earlier than Pap smear.

When no sign of malignancy is found with conventional methods, NEUMANN's test, with a proprietary algorithm, can establish the individual risk of each woman for cervical pre-cancer or cancer.  

One of the first clients of NEUMANN for its HPV diagnostics technology is the Synlab GenoID Molecular Laboratory, part of the Synlab Group, Europe's largest laboratory network.

The aim of NEUMANN is to prove its method can be a standalone solution for cervical cancer screening in any environment – including in developing countries where cytopathology is non-existent.

About NEUMANN

NEUMANN develops automated diagnostic testing systems for cancer screening and STDs. The company is majority owned by the X-Ventures Beta Venture Capital Fund co-financed by Hungarian private investors and the EIB in the Joint European Resources for Micro to Medium Enterprises (Jeremie) program.

www.neumanndx.com

Contact:

Ms Anna Faludi
email: anna.faludi@x-ventures.hu
tel: +36-70-454-3254

 

Photo - http://photos.prnewswire.com/prnh/20160128/326991   
Logo - http://photos.prnewswire.com/prnh/20160128/326990LOGO

 


'/>"/>
SOURCE NEUMANN
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. Der automatisierte Gebärmutterhalskrebs-Test von NEUMANN Diagnostics erreicht eine außergewöhnliche Genauigkeit
2. MGC Diagnostics Corporation to Report Second Quarter Fiscal 2013 Financial Results on Thursday, May 30, 2013
3. Alzheimer Market: Drugs, Therapeutics & Diagnostics Research Reports
4. Apnix Sleep Diagnostics Announces New Houston Sleep Apnea Treatments
5. MGC Diagnostics Corporation Reports 2013 Second Quarter Operating Results
6. QIAGEN Expands Pipeline of Promising New Biomarkers for Development of Personalized Healthcare Companion Diagnostics
7. Accelerate Diagnostics Announces Plans For Rights Offering To Stockholders
8. In Vitro Diagnostics - A Global Market Overview
9. Global In Vitro Diagnostics Markets Outpace Pharma Industry Growth, finds Frost & Sullivan
10. Quest Diagnostics CEO Steve Rusckowski Reaffirms Full-Year 2013 Guidance At The Jefferies 2013 Global Healthcare Conference
11. Quest Diagnostics and Hologic Form Strategic Alliance to Improve Womens Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/30/2017)... 2017 DarioHealth Corp. (NASDAQ: DRIO), a leading global digital ... that it will be presenting at the 7th annual LD Micro ... Erez Raphael , CEO, of DarioHealth will be giving the presentation ... on June 6th & 7th, 2017 at the Luxe Sunset Bel ... micro-cap space. About LD Micro ...
(Date:5/26/2017)... International plc (NASDAQ: ENDP ) announced today that ... Company in a fireside chat at Goldman Sachs, 38 th ... at 10:40 a.m. PT / 1:40 p.m. ET. The conference ... Palos Verdes, CA. A live webcast ... the Company,s website at http://www.endo.com/investors/overview . Participants should allow ...
(Date:5/22/2017)... VALLEY COTTAGE, N.Y. , May 22, 2017 ... natural antiviral treatment Gene-Eden-VIR/Novirin, announces the launch of ... in plain English, the results of a clinical ... after one year treatment with Gene-Eden-VIR/Novirin in individuals ... is important to note that there are no ...
Breaking Medicine Technology:
(Date:6/20/2017)... ... ... As a leading dental practice, Wall Centre Dental supports Stroke Awareness Month by ... gums in Vancouver, BC, may be developing gingivitis, the first stage of gum ... diabetes. Drs. Parviz Roshan, Siamak Tehrani and Milton Reskovich offer laser gum therapy to ...
(Date:6/20/2017)... ... June 20, 2017 , ... This year, participants ... focused on finding product improvements that could reduce the occurrence of unplanned extubations ... need help breathing or to provide medication. Sometimes, patient movement can cause unplanned ...
(Date:6/20/2017)... , ... June 20, 2017 , ... Uniform Advantage ... collection featuring seven new products designed to create tailored looks and athleisure-inspired outfits. UA ... and cotton easy care stretch twill. , With trendy looks hitting the medical community, ...
(Date:6/20/2017)... ... , ... John D'Eri, CEO of Rising Tide Car Wash , will ... during the Autism Society of America 's 49th annual conference to be held ... (DJFF) was founded in 2002 as the nation's first autism organization focused exclusively ...
(Date:6/20/2017)... ... June 20, 2017 , ... ... radio program, The Sharon Kleyne Hour Power of Water, Global Climate Change and ... to the world’s water crisis and how it affects the human eyes. ...
Breaking Medicine News(10 mins):